fda tirzepatide announcement confirms shortage is still over, gives compounders a grace period Is Tirzepatide FDA Approved?

For humans, 5-Amino-1MQ is still in the experimental stage, but anecdotal reports and early user experiences are trickling in

Long-term monitoring for pancreatitis or gallbladder issues is advised during treatment due to reported associations with GLP-1 receptor agonists

Importantly, these medications carry a boxed warning and contraindication for patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

GLP-1 RAs can help with weight loss by increasing feelings of fullness, reducing appetite, and slowing down gastric emptying, which can lead to reduced calorie intake